 Provider News NevadaSeptember 1, 2023 September 2023 Provider Newsletter Contents
NVBCBS-CDCRCM-035545-23 Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.Availity, LLC is an independent company providing administrative support services on behalf of the health plan. Claims that are submitted for laboratory services subject to the Clinical Laboratory Improvement Amendments of 1988 (CLIA) statute and regulations require additional information to be considered for payment. To be considered for reimbursement of clinical laboratory services, a valid CLIA certificate identification number must be reported on a 1500 Health Insurance Claim Form (CMS-1500) or its electronic equivalent for clinical laboratory services. The CLIA certificate identification number must be submitted in one of the following manners: Claim format and elements | CLIA number location options | Referring provider name and NPI number location options | Servicing laboratory physical location | CMS-1500 (formerly HCFA-1500) | Must be represented in field 23 | Submit the referring provider name and NPI number in fields 17 and 17b, respectively. | Submit the servicing provider name, full physical address, and NPI number in fields 32 and 32A, respectively, if the servicing address is not equal to the billing provider address. The servicing provider address must match the address associated with the CLIA ID entered in field 23. | HIPAA 5010 837 Professional | Must be represented in the 2300 loop, REF02 element, with qualifier of X4 in REF01 | Submit the referring provider name and NPI number in the 2310A loop, NM1 segment. | Physical address of servicing provider must be represented in the 2310C loop if not equal to the billing provider address and must match the address associated with the CLIA ID submitted in the 2300 loop, REF02. |
To be considered for reimbursement of reference laboratory services, the referring laboratory must be an independent clinical laboratory. Modifier 90 must be submitted to denote the referred laboratory procedure. Per the Centers for Medicare & Medicaid (CMS), an independent clinical laboratory that submits claims in paper format may not combine non-referred or self-performed and referred services on the same CMS-1500 claim form. Thus, when the referring laboratory bills for both non-referred and referred tests, it must submit two separate paper claims: one claim for non-referred tests and the other for referred tests. If submitted electronically, the reference laboratory must be represented in the 2300 or 2400 loop, REF02 element, with qualifier of F4 in REF01. Providers who have obtained a CLIA Waiver or Provider Performed Microscopy Procedure accreditation must include the QW modifier when any CLIA waived laboratory service is reported on a CMS-1500 claim form. Laboratory procedures must be rendered by an appropriately licensed or certified laboratory having the appropriate level of CLIA accreditation for the particular test performed. Thus, any claim that does not contain the CLIA ID, has an invalid ID, has a lab accreditation level that does not support the billed service code, does not have complete servicing provider demographic information and applicable reference laboratory provider demographic information, will be considered incomplete and rejected or denied. If you have questions, please contact your Provider Relationship Management representative. NVBCBS-CD-029251-23-CPN29147 You may have a relationship with CareMore Health as a partner in caring for your patients. CareMore delivers personalized, whole-person care to improve the quality of life for your patients, ensuring better outcomes and lowering costs to improve the health standards of the healthcare system. Soon, CareMore Health will have a new name: Carelon Health. Although the name will become Carelon Health, patients will still receive the same provider-led, patient-centered, and compassionate care from the same trusted doctors and nurses they see today. Carelon Health neighborhood care centers will continue to offer medical, behavioral, and wellness services in one location. Carelon Health’s advanced primary care can help you further enhance whole-person care. There’s nothing that you or your patients need to doNothing will change regarding patient referrals or your professional relationships with clinical staff. Carelon Health will continue to provide comprehensive and integrated care to address all aspects of patients’ health. If you are a current CareMore Health provider, you will receive a notification to update the name of CareMore Health to Carelon Health in your Provider Agreement in the coming months. Current CareMore Health patients will see the transition to Carelon Health in their fall 2023 enrollment materials. Please visit the CareMore Health website for more information on their programs. NVBCBS-CDCRCM-031886-23-CPN31467 The new Nevada Provider and Facility Manual is now live on our provider website, anthem.com. This recently updated provider manual contains everything you need to know about our programs and how we work with you to provide quality care to our members. You can access the provider manual by visiting anthem.com > Providers > Policies, Guidelines & Manuals. While we strive to keep our provider manual current, please be sure to check our Provider News page for the most up-to-date plan policy information. If you have questions about the provider manual or provider bulletins, contact your Provider Relations representative. We ask that you review your online provider directory information on a regular basis to ensure it is correct. Access your information by visiting anthem.com/provider, then under Provider Overview, choose Find Care. The Consolidated Appropriations Act (CAA) of 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. By reviewing your information regularly, you help us ensure your online provider directory information is current. Submit updates and corrections to your directory information by following the instructions on our Provider Maintenance webpage. We will send you an email acknowledging receipt of your request. Online update options include: - Add/change an address location.
- Name change.
- Provider leaving a group or a single location.
- Phone/fax number changes.
- Closing a practice location.
MULTI-BCBS-CM-034855-23-CPN34821 As part of our ongoing quality improvement efforts, we want you to know that some review requests may require documentation to substantiate the attestations that support the clinical appropriateness of the request. This documentation can be uploaded during the intake process. When requested, providers must submit such documentation from the patient’s medical record. If medical necessity is not supported through documents submitted, the request may be denied as not medically necessary. Such documentation is limited to what has been asserted via the prior authorization (PA) review attestations. If the request would be denied as not medically necessary, providers can participate in a PA discussion with an Carelon Medical Benefits Management physician reviewer. * Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. MULTI-BCBS-CM-034178-23-CPN34175 The American Cancer Society (ACS) recommends annual fecal immunochemical test (FIT) kit testing for all adults aged 45 and older with average risk for colon cancer. For these patients, the FIT kit is a convenient, cost-effective, and discreet testing option.1, 2 FIT kits offer a cost-effective, highly accurate option for colorectal cancer screening Screening with FIT kits is convenient and easier than ever. Adopting FIT screening into your practice can help increase patient adherence to colon cancer screening recommendations. Annual FIT improves screening rates and has also been shown to save lives.3 Anthem Blue Cross and Blue Shield network physicians and their patients have access to high-quality, low-cost colorectal cancer screening FIT kits through our National Lab partners Labcorp and Quest Diagnostics.* If you have specific questions, please contact the labs directly: To find Labcorp, Quest Diagnostics, and other participating labs in your patient’s plan network, select Find Care from the Provider Resources menu at anthem.com. References: 1. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.CA Cancer J Clin.2018;68(4):250-281. 2. Occult blood, fecal, immunoassay. Laboratory Corporation of America Holdings and Lexi-Comp Inc. 2021. Accessed April 11, 2022. https://bit.ly/3pRHPlV. 3. Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(12):1645-1658.
* Quest Diagnostics is an independent company providing preventive care technology and health risk assessments services on behalf of the health plan. MULTI-BCBS-CM-024720-23-CPN24527, MULTI-BCBS-CM-034185-23 In the April 2023 edition of Provider News, it was announced that for claims processed on and after May 15, 2023, we would update our claims editing process for outpatient facility claims by applying the outpatient code editor National Correct Coding Initiative (NCCI). This update was delayed and as a result, the NCCI edits will be applied to claims processed on and after October 1, 2023. As a reminder, NCCI edits are Centers for Medicaid & Medicare Services (CMS) developed guidelines to promote national correct coding based on industry standards for current coding practices. These edits provide an opportunity to shift certain existing back-end reviews to front-end adjudication for outpatient facility claims. While this may facilitate quicker claim adjudication, it may also cause claims to be denied if correct coding guidelines are not followed. This includes, but is not limited to, scenarios with procedure-to-procedure editing (for example, mutually exclusive or the procedure is a component of another procedure). For additional information, visit CMS.gov. If you have questions about this communication or need assistance with any other item, contact your Provider Relationship Management representative. Effective for all claims received on and after October 1, 2023, Anthem Blue Cross and Blue Shield (Anthem) is updating its outpatient facility editing system to align with correct coding guidelines. For claims received on or after October 1, 2023, when revenue codes 0278, 0636, 0760, 0761, 0762, and 0769 are billed with an inappropriate HCPCS or CPT® code, they will be denied. For assistance with coding guidelines, please refer to CPT coding guidelines and Encoder Pro. If you believe you have received a denial in error, please follow the standard claim dispute process for Anthem. During the COVID-19 public health emergency, Medicaid and Children’s Health Insurance Program (CHIP) members were able to stay enrolled in their current health coverage regardless of changes in eligibility or status. As Medicaid renewals begin again, your Medicaid and CHIP patients may have to take additional steps, which could include finding a new health plan. Patients who are receiving specialized care for medical conditions such as but not limited to pregnancy, chemotherapy, radiation therapy, or behavioral health therapy, may have additional concerns. They could be in the middle of treatment, scheduled for treatment, or on maintenance medications — and may be worried that they might lose access to their current care provider if they change health plans. The need for continuity of care in this changing landscapeWe’re committed to ensuring a smooth transition for your Medicaid and CHIP patients who are changing health plans. Our Continuity of Care/Transition of Care management team coordinates with you and your patients to ensure access to ongoing care. This includes a personalized evaluation of the member’s condition and network benefits to coordinate and minimize disruption of ongoing care: - Your patients can contact the number on the back of their member ID card and ask about our Transition of Care form. Once filled out, one of our dedicated nurse care managers will contact them to review their specialized care needs within 15 business days.
- Download our Medicaid provider manual to learn more about our Continuity of Care/Transition of Care Program. Refer to the table of contents and find Continuity of Care under the Responsibilities of the PCP/PCS section.
- Download our Commercial provider manual to learn more about our Continuity of Care/Transition of Care Program. Refer to the table of contents and find Continuity of Care/Transition of Care Program under the Quality Improvement Program section.
A proactive approach to prior authorizationsFor patients with CarelonRx, Inc.* as their pharmacy benefit manager and who are on maintenance medications or other medications for treatment, their existing, approved prior authorizations will automatically transfer to their new Anthem individual and family health plan, and there will be a one-time prior authorization applied for nonformulary medications. This will allow your patients to continue to fill their current medications and allow additional time to initiate the prior authorization process for any formulary differences. You and your patients can count on us for supportYour patients who are receiving specialized care may have concerns about continuing their care and staying with their current care providers. We want you to feel confident you have resources and answers to guide them. Together, we can ease your patients’ potential concerns and ensure a smooth transition for those who choose an Anthem individual and family health plan. If you would like more information, contact your Provider Relationship Management representative, or call the number on the back of the patient’s ID card. * CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan. NVBCBS-CDCM-026685-23-CPN26000 Anthem Blue Cross and Blue Shield Healthcare Solutions (Anthem) is transitioning to the Availity Essentials* Authorization application. You may already be familiar with the Availity multi-payer Authorization app because thousands of providers are already using it for submitting prior authorizations for other payers. Anthem is eager to make it available to our providers, too. In September, you can begin using the same authorization app you use for other payers for Anthem. Interactive care reviewer (ICR) is still availableIf you need to refer to an authorization that was submitted through ICR, you will still have access to that information. We’ve developed a pathway to access your ICR dashboard. You will simply follow the prompts provided through the Availity Authorization app. To make it even more convenient, you can pin your authorizations from the ICR application to your Availity Authorization app dashboard. Innovation in processWhile we grow the Availity Authorization app to provide you with Anthem-specific information, you will still need to access ICR for: - Appeals.
- Behavioral health authorizations and inquiries.
- Federal Employee Program® authorizations and inquiries.
- HealthLink authorizations and inquiries.
- Medical specialty prescription authorizations and inquiries.
Notices in the Availity Authorization app will guide you through the process for accessing ICR for alternate authorization and appeals functions. Training is availableIf you aren’t already familiar with the Availity Authorization app, training is available. Visit the training site to enroll for an upcoming live webcast or to access an on-demand recording at the Availity Authorization training site. Now, give it a tryAccessing the Availity Authorization app is easy. Ask your organization’s Availity administrator to ensure you have the Authorization role assignment. Without the role assignment, you will not be able to access the Authorization application. Then, just log onto Availity.com to access the app through the Patient Registration tab by selecting Authorizations and Referrals. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. NVBCBS-CD-030957-23-CPN29378 Digital Request for Additional Information (Digital RFAI) is the fastest and easiest way to get us the documents we need to process your claim. Now, it is even better! We’ve added filter, sort, and search features for greater productivity. New filtering functions are ideal for organizations where more than one person is responsible for submitting claim attachments. Another great feature: your filters are saved (locked) – so you can see your desired filter view each time you log on but easily clear them when your search criteria changes.

We are committed to shared success and reporting is just another way we are giving Digital RFAI users a productivity boost. We’ve added reporting fields that can be used for both History and Inbox reports. Fields available for History and Inbox reports
Expanded reporting fields are downloadable! Use the download option to meet your specific reporting requirements. 
We’re here to help! Want to know more about receiving digital notifications for faster claims processing? Visit the Digital RFAI learning microsite or reach out to your Provider Relations Account Manager. MULTI-BCBS-CM-035616-23-CPN35217 Description/Approach Provider performance can vary widely in relation to efficiency and quality. Our goal as your Medicare health plan partner is to ensure our members receive high-quality care that leads to improved member health outcomes across a wide range of variables. We will add a new sorting option on the Find Care tool for members to leverage when they are searching for a non-PCP specialist provider. This sorting option, called Personalized Match Phase 1, is based on each provider’s score relative to their peers in the patient’s preferred mileage search radius. Providers will be listed in order of their total score, though no individual scores will appear within the tool or be visible to the covered patients. The Personalized Match Phase 1 algorithm will be based on quality and efficiency criteria to assist members in making more informed choices about their medical care. Other sorting options will still be available on Find Care for our members. Members should consider a variety of factors when making decisions for choosing a specialist provider to manage their care. We evaluate provider groups and individual providers annually, using updated quality and efficiency methodologies and data. Continue reading the rest of this article * Optum is an independent company providing assessment and reporting services on behalf of the health plan. MULTI-BCBS-CR-032277-23-CPN32264 ATTACHMENTS (available on web): Personalized Match Phase 1: Specialist Provider Overview (pdf - 0.59mb) We understand that providing the information needed to process a claim can cause payment delays, and the manual methods associated with mailing letters and returning information non-digitally is costly and inefficient. We’re changing that by implementing a new process: Digital Request for Additional Information (Digital RFAI), and we’re inviting you to participate. Digital requests for additional information are 50% faster than returning documentation any other way — making it the most efficient way to receive and return information — resulting in faster claim payments. Participation in Digital RFAI is easy- Registration:
- Your organization’s Availity* administrator will register for Medical Attachments:
- This enables you to receive digital notices (instead of paper) and to attach the requested documents directly to your claim.
- Ensure all of your billing NPIs/TINs are registered.
- User roles:
- Your Availity administrator will also update or add new users with these specific role assignments through Availity Essentials:
- Claims Status
- Medical Attachments
- This enables the users to view the Availity Attachment Dashboard.
- Ready to go:
- After the registration and user roles are completed on Availity, the Digital RFAI process is ready to go.
- Requests will automatically appear on the Attachments Dashboard each morning (when documents are needed).
Additional supportYou, your organization’s Availity administrator, or other members of your team may need additional support – and we’re to help: - For Availity Administrators: Take this training to ensure your NPIs are registered properly.
- For those sending attachments: Take this user training to learn about accessing notifications, sorting and filtering, and other enhancements that improve your experience.
Through our efforts, we are committed to reducing administrative burden and ensuring timely payments because we value you, our care provider partner. For additional resources, visit the Digital RFAI webpage or contact your Provider Relations Account Manager. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. MULTI-BCBS-CM-036134-23-CPN35203 Anthem continues to work to enhance our care provider data management system, which should significantly improve your data accuracy, transparency, and experience. In the April 2023 edition of Provider News, we notified our care provider partners about our plans to begin implementing changes to our data management system. Since that time, we’ve continued to include updates and reminders in Provider News. We will begin phasing in these changes this month — September 2023. What is important? - As a reminder, you are contractually required to report any practice changes.
- Tell us when care providers join your group. Notifying us in a timely manner prior to the new care provider rendering care to our members is important.
- Ensure all your contracted care providers’ information is uploaded into our care provider data management system prior to rendering services.
- Claims received for services rendered by a care provider who has not yet been added to your contract will be rejected or processed as out of network.
What you need to know about billing As part of this data management system upgrade, Anthem is applying the Centers for Medicare & Medicaid Services (CMS) billing guidelines to hold care providers accountable for billing claims data correctly. Beginning in early 2024, claims submitted using rendering care providers who have not been added to your contract by the date of service billed, or with missing or incorrect National Provider Identifiers (NPIs), will be rejected for more information or processed as out of network. Other important and helpful remindersSubmitting claims with complete and correct information is critical to ensuring Anthem can process your claims efficiently and accurately: - Bill according to standard billing guidelines.
- Review your billing practices carefully to ensure the proper tax identification number (TIN), NPI, and rendering care provider information (if applicable) are submitted correctly.
- Bill with a in State service location.
More information is available online at Provider Policies, Guidelines and Manuals | Anthem.com. CMS regulations and guidance can be found here. Starting mid-September, search for patient information in Availity Essentials* Eligibility and Benefits without having a member ID. We’ve updated and streamlined the process to eliminate the need for the member ID while maintaining the highest HIPAA standards. Easily search for patient eligibility and benefits details using the Patient Search option of patient last name, patient first name, date of birth, and patient zip code. Find Eligibility and Benefits Inquiry on Availity’s top menu bar under Patient Registration. Once it becomes available, make sure to use the new search feature when you need to find member information and do not have access to the member ID. Need the member ID for another capability in Availity Essentials? When you use the new search option in Eligibility and Benefits Inquiry and see the eligibility and benefits details, the member’s current ID details will be available and allow you to transact within other digital capabilities where the member ID is required. Watch for more information on the Availity Essentials home page under News and Announcements to notify you when this feature is available. Get access to Availity Essentials nowIf you and your organization aren’t currently registered for Availity Essentials, now is the time to make that happen. Availity Essentials offers secure online access for working together and is free to our providers. To register, visit the availity.com Registration Information page. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. MULTI-BCBS-CM-025687-23-CPN25562 Register today for the youth mental health forum hosted by Anthem Blue Cross and Blue Shield (Anthem) and Motivo* for Anthem providers on September 27, 2023. Wednesday, September 27, 2023 3:30 to 5 p.m. Eastern time This important event will address the critical need to engage young people in leading their mental health. By deepening the discussion on youth mental health, we can do our part to foster a culture of understanding and support for youth and young adults. Authentic conversations lead to reducing implicit bias and improving the health and wellbeing of all Americans and the communities in which we live and serve. Please join us to hear from a diverse panel of experienced professionals and young leaders as we explore the challenges experienced by today’s youth, amplify the experiences and ideas of young people, and equip attendees with practical tools and innovative approaches to create meaningful change. Each forum will continue the exploration of ways we can reduce disparities in healthcare, demonstrate cultural humility, address, and deconstruct bias, have difficult and productive conversations, learn about valuable resources, increase inclusion, advance equity in healthcare. Please register for this event by visiting this link. * Motivo is an independent company providing a virtual forum on behalf of the health plan. MULTI-BCBS-CRCM-029408-23-CPN29379 On August 19, 2022, September 15, 2022, November 18, 2022, December 22, 2022, May 2, 2023, and May 19, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield Healthcare Solutions (Anthem). These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: Newly published criteria.
- Revised: Addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | September 29, 2023 | *CC-0237 | Qalsody (tofersen) | New | September 29, 2023 | *CC-0238 | Hydroxyprogesterone caproate | New | September 29, 2023 | *CC-0240 | Zynyz (retifanlimab-dlwr) | New | September 29, 2023 | CC-0165 | Trodelvy (sacituzumab govitecan) | Revised | September 29, 2023 | CC-0002 | Colony Stimulating Factor Agents | Revised | September 29, 2023 | CC-0128 | Tecentriq (atezolizumab) | Revised | September 29, 2023 | CC-0098 | Doxorubicin Liposome (Doxil, Lipodox) | Revised | September 29, 2023 | CC-0101 | Torisel (temsirolimus) | Revised | September 29, 2023 | CC-0107 | Bevacizumab for Non-Ophthalmologic Indications | Revised | September 29, 2023 | CC-0143 | Polivy (polatuzumab vedotin-piiq) | Revised | September 29, 2023 | CC-0092 | Adcetris (brentuximab vedotin) | Revised | September 29, 2023 | CC-0095 | Velcade (bortezomib) | Revised | September 29, 2023 | CC-0105 | Vectibix (panitumumab) | Revised | September 29, 2023 | CC-0178 | Synribo (omacetaxine mepesuccinate) | Revised | September 29, 2023 | CC-0114 | Jevtana (cabazitaxel) | Revised | September 29, 2023 | CC-0145 | Libtayo (cemiplimab-rwlc) | Revised | September 29, 2023 | *CC-0032 | Botulinum Toxin | Revised | September 29, 2023 | CC-0068 | Growth Hormone | Revised | September 29, 2023 | *CC-0057 | Krystexxa (pegloticase) | Revised | September 29, 2023 | *CC-0125 | Opdivo (nivolumab) | Revised | September 29, 2023 | *CC-0225 | Tzield (teplizumab-mzwv) | Revised | September 29, 2023 | *CC-0167 | Rituximab Agents for Oncologic Indications | Revised | September 29, 2023 | *CC-0075 | Rituximab Agents for Non-Oncologic Indications | Revised | September 29, 2023 | *CC-0182 | Iron Agents | Revised | September 29, 2023 | *CC-0124 | Keytruda (pembrolizumab) | Revised |
NVBCBS-CD-031929-23-CPN30759 Clinical Criteria Updates On December 22, 2022, May 2, 2023, and May 19, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield (Anthem). These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: Newly published criteria
- Revised: Addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | September 18, 2023 | *CC-0237 | Qalsody (tofersen) | New | September 18, 2023 | *CC-0238 | Hydroxyprogesterone caproate | New | September 18, 2023 | *CC-0240 | Zynyz (retifanlimab-dlwr) | New | September 18, 2023 | CC-0165 | Trodelvy (sacituzumab govitecan) | Revised | September 18, 2023 | CC-0002 | Colony Stimulating Factor Agents | Revised | September 18, 2023 | CC-0128 | Tecentriq (atezolizumab) | Revised | September 18, 2023 | CC-0098 | Doxorubicin Liposome (Doxil, Lipodox) | Revised | September 18, 2023 | CC-0101 | Torisel (temsirolimus) | Revised | September 18, 2023 | CC-0107 | Bevacizumab for Non-Ophthalmologic Indications | Revised | September 18, 2023 | CC-0143 | Polivy (polatuzumab vedotin-piiq) | Revised | September 18, 2023 | CC-0092 | Adcetris (brentuximab vedotin) | Revised | September 18, 2023 | CC-0095 | Velcade (bortezomib) | Revised | September 18, 2023 | CC-0105 | Vectibix (panitumumab) | Revised | September 18, 2023 | CC-0178 | Synribo (omacetaxine mepesuccinate) | Revised | September 18, 2023 | CC-0114 | Jevtana (cabazitaxel) | Revised | September 18, 2023 | CC-0145 | Libtayo (cemiplimab-rwlc) | Revised | September 18, 2023 | *CC-0032 | Botulinum Toxin | Revised | September 18, 2023 | CC-0068 | Growth Hormone | Revised | September 18, 2023 | *CC-0057 | Krystexxa (pegloticase) | Revised | September 18, 2023 | *CC-0125 | Opdivo (nivolumab) | Revised | September 18, 2023 | *CC-0225 | Tzield (teplizumab-mzwv) | Revised | September 18, 2023 | *CC-0124 | Keytruda (pembrolizumab) | Revised |
MULTI-BCBS-CR-031946-23-CPN30755 Effective September 1, 2023, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield Healthcare Solutions for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines (including definitions and specific contract provisions/exclusions) take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | A0888 | Noncovered Ambulance Mileage | E0465 | Home ventilator, any type, used with invasive interface, (for example, tracheostomy tube) | E0467 | Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components, and supplies for all functions | E2500 | Speech generating device, digitized speech, using pre-recorded messages, 8 min. or less | E2502 | Speech generating device, digitized speech, using pre-recorded messages, 8-20 min. | E2506 | Speech generating device, digitized speech, using pre-recorded messages, over 40 min. | E2508 | Speech generating device, synthesized speech, requiring message formulation by spelling | E2512 | Accessory for speech generating device, mounting system |
To request PA, you may use one of the following methods: - Web: Once logged in to Availity Essentials* at https://availity.com
- Fax: 800-964-3627
- Phone: 844-396-2330
Not all PA requirements are listed here. Detailed PA requirements are available to providers at https://providers.anthem.com/nevada-provider/communications/archives on the Resources tab or, for contracted providers, by accessing Availity.com. Providers may also call Provider Services at 844-396-2330 for assistance with PA requirements. UM AROW #4230
* Availity, LLC is an independent company providing administrative support services on behalf of the health plan. NVBCBS-CD-023885-23-CPN23495 Effective December 1, 2023, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 64581 | Incision for implantation of neurostimulator electrode array; sacral nerve (transforaminal placement) | 64628 | Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral | C1764 | Event recorder, cardiac (implantable) | E0466 | Home ventilator, any type, used with non-invasive interface, (for example, mask, chest shell) | E0766 | Electrical stimulation device used for cancer treatment, includes all accessories, any type | L5845 | Knee-Shin Sys Stance Flexion | L5910 | Endo Below Knee Alignable Sy |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com.* Providers may also call the number on the back of the member’s ID card for assistance with PA requirements. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan.
UM AROW# 4489 MULTI-BCBS-CR-028201-23-CPN27653 Request for Termination of Service Form Use this form to terminate service with an existing provider to allow the new provider to submit an authorization request. The new provider completes this form. Please submit this form online with the request for prior authorization. Beginning with dates of service on or after December 1, 2023, Anthem Blue Cross and Blue Shield will expand the current Documentation Standards for Episodes of Care — Professional reimbursement policy to apply to facility providers. This policy outlines how and what elements must be documented for an episode of care. The policy will be retitled Documentation Standards for Episodes of Care — Professional and Facility. For specific policy details, visit the reimbursement policy page at Anthem.com. In the July 2023 edition of Provider News, reimbursement policy page we announced multiple updates to the Prolonged Services – Professional reimbursement policy Nevada effective October 1, 2023. To clarify, the update to “remove language requiring providers to report start and stop times for reimbursement eligibility” was effective as of May 19, 2023. Effective as of June 14, 2023, Anthem Blue Cross and Blue Shield updated the Documentation and Reporting Guidelines for Evaluation and Management (E/M) Services reimbursement policy to include the 2021 American Medical Association (AMA) CPT® Level of Medical Decision Making (MDM) table to align with the 2021-2023 Centers for Medicare & Medicaid Services (CMS) and AMA-CPT code changes. This table will be listed under the policy section titled Selecting a Level of Medical Decision Making for Coding an E/M Service. When determining the level of E/M service using MDM, this table will be used instead of the 1995/1997 CMS risk tables and the Marshfield Clinic tables. Additional updates to this reimbursement policy are as follows: - Documentation submitted in accordance with this reimbursement policy will remain subject to signature and other requirements as stated in the related Documentation for Episodes of Care reimbursement policy. Therefore, the policy was updated to include the following note: All documents are subject to the Documentation Requirements for Episodes of Care policy.
- The Related Coding section was expanded to include “other” E/M services, as defined in the policy.
For specific policy details, visit the corresponding reimbursement policy page from the list below: Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. Beginning with dates of service on or after December 1, 2023, Anthem Blue Cross and Blue Shield (Anthem) will update the Place of Service – Facility reimbursement policy to include professional services billed under revenue codes 960-983 expanded to 960-989. According to the policy, Evaluation & Management (E/M) services and other professional services: - Must be billed on a CMS-1500 claim form; and
- Are not reimbursable if billed on a UB-04 claim form (excluding E/M services rendered in an emergency room and billed with emergency room revenue codes).
The policy will be retitled Facility Guidelines for Claims related to Professional Services – Facility. For specific policy details, visit the Nevada reimbursement policy page at anthem.com.MULTI-BCBS-CM-034779-23-CPN34757 Effective June 14, 2023, Anthem Blue Cross and Blue Shield’s split care surgical modifier language was removed from the Global Surgical Package — Professional reimbursement policy and added to a new standalone reimbursement policy titled Split Care Surgical Modifiers — Professional. This policy allows reimbursement based on a percentage of the fee schedule or contracted/negotiated rate for the surgical procedure. The percentage is determined by the modifier that is appended to the procedure code. The Related Coding section of the policy identifies the applicable modifiers and standard reimbursement percentages. For specific policy details, visit the reimbursement policy page at anthem.com. Anthem Blue Cross and Blue Shield (Anthem) would like to remind care providers that our Findlay account members will present with ID cards with an alpha prefix YFW or YFY: - The YFW alpha prefix for Findlay will access the PPO network for Anthem.
- The YFY alpha prefix for Findlay will access the Open Access HMO network for Anthem:
- Unlike a traditional HMO, the Open Access HMO for Anthem allows members to obtain care from specialists without a referral from their primary care provider (PCP).
- When checking eligibility and benefits within the Availity Essentials platform*, these members will show:
- Insurance type: Point of Service (POS).
- Plan/product: NEVADA BLUE ADVANTAGE POS
*Note: The alpha prefix YFY is used for both the Open Access HMO and HMO Guided Access. Plans with the YFY alpha prefix that are not from Findlay are subject to referral requirements. Findlay account members do not require a referral to obtain care. Below are images of the front and back of the member ID card that a Findlay account member may present. 


If you have questions, contact Provider Services using the number on the back of the member’s ID card. *Availity, LLC is an independent company providing administrative support services on behalf of the health plan. NVBCBS-CM-036507-23 Your Dual-Eligible Special Needs Plan (DSNP) member’s Individualized Care Plan (ICP/CP) is available on Availity* at www.availity.com. We would like the opportunity to discuss identified problems/needs and collaborate on ways to assist the member in meeting their care plan goals. The member and/or caregiver are central to the process and are also invited to attend the Interdisciplinary Care Team (ICT) meeting. Your participation is important. If you would like to participate in the ICT meeting, call us back as soon as possible at 844-408-6568. When contacting us, include the member’s name, date of birth, and Medicare identification number. The case manager will reach out to set up the meeting. Any care plan changes made from the ICT meeting will be available for you to review on Availity one-to-two working days after the meeting. To access the care plan information, your Availity administrator must register you for access to Member Clinical Reports and complete the registration process using Payer Spaces > Preference Center. Once the registration piece is complete, log in to Availity, select Payer Spaces > Payer Tile > Alerts Hub to access the member’s ICP. We are available Monday through Friday, 8 a.m. to 5 p.m., excluding holidays. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. MULTI-BCBS-CR-024214-23-CPN23812 Specialty pharmacy updates for Anthem Blue Cross and Blue Shield (Anthem) are listed below. Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by the Anthem's Medical Specialty Drug Review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc.*, a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Including the National Drug Code (NDC) code on your claim may help expedite claim processing of drugs billed with a not otherwise classified (NOC) code. Prior authorization updatesEffective for dates of service on and after December 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these site of prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0241 | Elfabrio (pegunigalsidase alfa-iwxj) | J3490, J3590 | CC-0242* | Epkinly (epcoritamab-bysp) | C9399, J3490, J3590, J9999 | CC-0243 | Vyjuvek (beremagene geperpavec) | J3490, J3590 | CC-0062 | Yuflyma (adalimumab-aaty) | J3490, J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Quantity limit updatesEffective for dates of service on and after December 1, 2023, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT® Code(s) | CC-0241 | Elfabrio (pegunigalsidase alfa-iwxj) | J3490, J3590 | CC-0228 | Leqembi (lecanemab) | J0174 | CC-0243 | Vyjuvek (beremagene geperpavec) | J3490, J3590 | CC-0062 | Yuflyma (adalimumab-aaty) | J3490, J3590 |
* Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. MULTI-BCBS-CM-034766-23-CPN34723 Effective April 5, 2023, Sublocade® can no longer be filled at Accredo Specialty Pharmacy.* Members currently filling through Accredo Specialty Pharmacy will need to switch to CVS Specialty Pharmacy.* A member of the CVS Specialty Pharmacy Care team will be contacting prescribers to obtain a new prescription. Prescribers can contact CVS Specialty Pharmacy at 877-254-0015. * Accredo Specialty Pharmacy is an independent company providing pharmacy services on behalf of the health plan. CVS is an independent company providing pharmacy services on behalf of the health plan. MULTI-BCBS-CM-034784-23-CPN34761 The following Part B medications from the current Clinical Criteria Guidelines are included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below. There are no clinical changes to Clinical Criteria CC-005, Hyaluronan Injections. Based on feedback, the table listing the preferred and non-preferred products has been updated to present the information in a more useful manner. The updated table identifies preferred alternatives based on injection series. Clinical Criteria Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria. Clinical UM Guidelines | Preferred drug(s) | Nonpreferred drug(s) | CC-0005 | Single injection: Durolane Three injection series: Euflexxa Gel-Syn Five injection series: Supartz | Single injection: Gel-One Monovisc Synvisc-one Two injection series: Hymovis Three Injection series: Orthovisc Synojoynt Synvisc Triluron Trivisc Five injection series: Genvisc 850 Hyalgan Visco-3 |
MULTI-BCBS-CR-031138-23-CPN30365 **This collateral ran originally in the July 1, 2023, newsletter and was also posted on the provider portal with an October 1, 2023, effective date. The new date of service will begin on November 1, 2023.** Effective for dates of service on and after November 1, 2023, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | J1931 | Aldurazyme (laronidase) | J0256 | Aralast NP (alpha-1 proteinase inhibitor), Prolastin-C (alpha-1 proteinase inhibitor), Zemaira (alpha-1 proteinase inhibitor) | J1786 | Cerezyme (imiglucerase) | J0584 | Crysvita (burosumab-twza) | J1743 | Elaprase (idursulfase) | J3060 | Elelyso (taliglucerase) | J0180 | Fabrazyme (agalsidase beta) | J0257 | Glassia (alpha-1 proteinase inhibitor) | J0638 | Ilaris (canakinumab) | J0221 | Lumizyme (alglucosidase alfa) | J3397 | Mepsevii (vestronidase alfa) | J1458 | Naglazyme (galsulfase) | J0219 | Nexviazyme (avalglucosidase alfa-ngpt) | J0222 | Onpattro (patisiran) | J1322 | Vimizim (elosulfase alfa) | J3385 | Vpriv (velaglucerase) | J0775 | Xiaflex (collagenase clostridium histolyticum) |
MULTI-BCBS-CR-032240-23-CPN31947 Prior authorization updates for medications billed under the medical benefit Effective for dates of service on and after September 1, 2023, the following medication codes billed on medical claims will require prior authorization in accordance with the requirements of the current or new Clinical Criteria documents. Please note, inclusion of a national drug code on your medical claim is necessary for claims processing. Visit the Clinical Criteria website to search for the following specific Clinical Criteria listed. Clinical Criteria | HCPCS or CPT® code(s) | Drug name | CC-0065 | C9399, J7199 | Altuviiio (antihemophilic factor recombinant) |
If you have questions about this communication or need assistance with any other item, contact your local Provider Relationship Management representative or call Provider Services at 844-396-2330. Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. NVBCBS-CD-028796-23-CPN28733 Anthem Blue Cross and Blue Shield reimburses providers for Medicare Advantage medication reconciliation. Please see the FAQ to learn how to receive reimbursement for post inpatient discharge medication reconciliation. |